These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 25377559)

  • 1. Leukemia cells make ruthless competitors.
    Bhatia R
    Blood; 2014 Nov; 124(19):2900-1. PubMed ID: 25377559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JAK2V617F+ myeloproliferative neoplasm clones evoke paracrine DNA damage to adjacent normal cells through secretion of lipocalin-2.
    Kagoya Y; Yoshimi A; Tsuruta-Kishino T; Arai S; Satoh T; Akira S; Kurokawa M
    Blood; 2014 Nov; 124(19):2996-3006. PubMed ID: 25217696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipocalin 2 as a membrane-reorganizing agent.
    Lingwood D
    Sci Signal; 2014 Aug; 7(338):pe19. PubMed ID: 25118326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of 24p3 and interleukin-17A in autoimmune hepatitis].
    He B; Gao WD; Song GQ; Wang CC; Yang ML; Liu QS
    Zhonghua Gan Zang Bing Za Zhi; 2007 Sep; 15(9):709-10. PubMed ID: 17903384
    [No Abstract]   [Full Text] [Related]  

  • 5. Requirement of lipocalin 2 for hematopoietic and solid tumor malignancies.
    Leng X; Ding T; Arlinghaus R
    Adv Enzyme Regul; 2009; 49(1):142-6. PubMed ID: 19344630
    [No Abstract]   [Full Text] [Related]  

  • 6. Mesenchymal stem cell therapy in acute lung injury: is it time for a clinical trial?
    Mac Sweeney R; McAuley DF
    Thorax; 2012 Jun; 67(6):475-6. PubMed ID: 22504891
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipocalin-2 is associated with modulation of disease phenotype in a patient with concurrent JAK2-V617F and BCR-ABL mutation.
    Nadarajan VS; Ang CH; Bee PC
    Eur J Haematol; 2012 Feb; 88(2):175-8. PubMed ID: 21950422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte apoptosis: death by a secreted lipocalin?
    Yousefi S; Simon HU
    Cell Death Differ; 2002 Jun; 9(6):595-7. PubMed ID: 12032667
    [No Abstract]   [Full Text] [Related]  

  • 9. Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinib.
    Pacilli A; Fanelli T; Mannarelli C; Rotunno G; Pancrazzi A; Vannucchi AM; Guglielmelli P
    Hematol Oncol; 2018 Feb; 36(1):357-359. PubMed ID: 28474777
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell biology: iron thievery.
    Barasch J; Mori K
    Nature; 2004 Dec; 432(7019):811-3. PubMed ID: 15602535
    [No Abstract]   [Full Text] [Related]  

  • 11. Concomitant detection of BCR-ABL translocation and JAK2 V617F mutation in five patients with myeloproliferative neoplasm at diagnosis.
    Cappetta M; Pérez V; Zubillaga MN; Elizondo V; Manrique G; Prosper I; Boschi S; Bonomi R; Pomoli S; Díaz L; Martínez L; Uriarte MR
    Int J Lab Hematol; 2013 Feb; 35(1):e4-5. PubMed ID: 23062104
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical implications of JAK2 mutations in myeloproliferative disorders.
    Knoops L; Hermans C; Ferrant A; Constantinescu SN
    Acta Clin Belg; 2008; 63(2):93-8. PubMed ID: 18575049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic profiling in Lipocalin 2 deficient mice under normal and inflammatory conditions.
    Labbus K; Henning M; Borkham-Kamphorst E; Geisler C; Berger T; Mak TW; Knüchel R; Meyer HE; Weiskirchen R; Henkel C
    J Proteomics; 2013 Jan; 78():188-96. PubMed ID: 23219901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-induced expression of lipocalin-2 in brain endothelial cells: relationship with interleukin-6, cyclooxygenase-2 and the febrile response.
    Hamzic N; Blomqvist A; Nilsberth C
    J Neuroendocrinol; 2013 Mar; 25(3):271-80. PubMed ID: 23046379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipocalin-2 test in distinguishing acute lung injury cases from septic mice without acute lung injury.
    Zeng G; Jia CW; Liu J; Guo SB
    Chin Med Sci J; 2014 Jun; 29(2):65-77. PubMed ID: 24998227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipocalin-2 controls the expression of SDF-1 and the number of responsive cells in bone.
    Costa D; Biticchi R; Negrini S; Tasso R; Cancedda R; Descalzi F; Pennesi G; Tavella S
    Cytokine; 2010 Jul; 51(1):47-52. PubMed ID: 20362461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinuria: New therapeutic strategy for proteinuria.
    Edwards JK
    Nat Rev Nephrol; 2016 Apr; 12(4):196. PubMed ID: 26853270
    [No Abstract]   [Full Text] [Related]  

  • 18. A response to reimportation.
    Newcomer M
    Structure; 2005 Jan; 13(1):1-2. PubMed ID: 15642254
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipocalin-2 released in response to cerebral ischaemia mediates reperfusion injury in mice.
    Wang G; Weng YC; Han X; Whaley JD; McCrae KR; Chou WH
    J Cell Mol Med; 2015 Jul; 19(7):1637-45. PubMed ID: 25702801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury--where do we stand today?
    Schmidt-Ott KM
    Nephrol Dial Transplant; 2011 Mar; 26(3):762-4. PubMed ID: 21310736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.